Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation

Keratins 8 and 18 belong to the keratin family of intermediate filament (IF) proteins and constitute a hallmark for all simple epithelia, including the liver. Hepatocyte IFs are made solely of keratins 8 and 18 (K8/K18). In these cells, the loss of one partner via a targeted null mutation in the germline results in hepatocytes lacking K8/K18 IFs, thus providing a model of choice for examining the function(s) of simple epithelium keratins. Here, we report that K8-null mouse hepatocytes in primary culture and in vivo are three- to fourfold more sensitive than wild-type (WT) mouse hepatocytes to Fas-mediated apoptosis after stimulation with Jo2, an agonistic antibody of Fas ligand. This increased sensitivity is associated with a higher and more rapid caspase-3 activation and DNA fragmentation. In contrast, no difference in apoptosis is observed between cultured K8-null and WT hepatocytes after addition of the Fas-related death-factors tumor necrosis factor (TNF) α or TNF-related apoptosis-inducing ligand. Analyses of the Fas distribution in K8-null and WT hepatocytes in culture and in situ demonstrate a more prominent targeting of the receptor to the surface membrane of K8-null hepatocytes. Moreover, altering Fas trafficking by disrupting microtubules with colchicine reduces by twofold the protection generated against Jo2-induced lethal action in K8-null versus WT hepatocytes. Together, the results strongly suggest that simple epithelium K8/K18 provide resistance to Fas-mediated apoptosis and that this protection occurs through a modulation of Fas targeting to the cell surface.

[1]  M. Omary,et al.  Keratin 8 mutations in patients with cryptogenic liver disease. , 2001, The New England journal of medicine.

[2]  G. Gores,et al.  Apoptosis in cancer: cause and cure , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[3]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[4]  M. Hengartner The biochemistry of apoptosis , 2000, Nature.

[5]  M. Seldin,et al.  Fas-mediated apoptosis of proliferating, transiently growth-arrested, and senescent normal human fibroblasts. , 2000, Experimental cell research.

[6]  P. Matarrese,et al.  CD95 (APO‐1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway , 2000, The EMBO journal.

[7]  R. Goldman,et al.  Intermediate Filaments on the Move , 2000, The Journal of cell biology.

[8]  M. Manns,et al.  Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure , 2000 .

[9]  M. Peter,et al.  Identification of the Cytolinker Plectin as a Major Early In Vivo Substrate for Caspase 8 during CD95- and Tumor Necrosis Factor Receptor-Mediated Apoptosis , 2000, Molecular and Cellular Biology.

[10]  M. Black,et al.  Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant. , 2000, Human gene therapy.

[11]  S. Fulda,et al.  Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. , 2000, Cancer research.

[12]  G. Gores,et al.  Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[13]  S. Kanzler,et al.  Apoptosis and the liver. , 2000, Seminars in cancer biology.

[14]  D. Lawrence,et al.  Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. , 2000, Immunity.

[15]  J. Blenis,et al.  FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. , 2000, Immunity.

[16]  S. Strom,et al.  Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.

[17]  C. Ware,et al.  Keratin-Dependent, Epithelial Resistance to Tumor Necrosis Factor-Induced Apoptosis , 2000, The Journal of cell biology.

[18]  K. Zatloukal,et al.  Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. , 2000, The American journal of pathology.

[19]  N. Kaplowitz,et al.  Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody. , 2000, The Journal of clinical investigation.

[20]  S. Cosulich,et al.  The role of protein kinase B and mitogen‐activated protein kinase in epidermal growth factor and tumor necrosis factor α–mediated rat hepatocyte survival and apoptosis , 2000, Hepatology.

[21]  U. Aebi,et al.  Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. , 2000, Current opinion in cell biology.

[22]  A. Hara,et al.  Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice , 2000, British Journal of Cancer.

[23]  M. Rolfe,et al.  Role for tumor necrosis factor α receptor 1 and interleukin‐1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin , 1999, Hepatology.

[24]  S. Nagata,et al.  Fas ligand-induced apoptosis. , 1999, Annual review of genetics.

[25]  P. Krammer CD95(APO-1/Fas)-mediated apoptosis: live and let die. , 1999, Advances in immunology.

[26]  M. Omary,et al.  The cytoskeleton of digestive epithelia in health and disease. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[27]  E. Martínez-Salas Internal ribosome entry site biology and its use in expression vectors. , 1999, Current opinion in biotechnology.

[28]  J. Fox,et al.  Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. , 1999, The American journal of pathology.

[29]  S. Anderson,et al.  Epidermal Growth Factor Protects Epithelial Cells against Fas-induced Apoptosis , 1999, The Journal of Biological Chemistry.

[30]  J. Downward,et al.  Role of Phosphoinositide 3-Kinase in Activation of Ras and Mitogen-Activated Protein Kinase by Epidermal Growth Factor , 1999, Molecular and Cellular Biology.

[31]  V. Dixit,et al.  Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.

[32]  D. Tang,et al.  Cycloheximide-induced T-cell Death Is Mediated by a Fas-associated Death Domain-dependent Mechanism* , 1999, The Journal of Biological Chemistry.

[33]  Ingo Schmitz,et al.  The Role of c-FLIP in Modulation of CD95-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[34]  E. Reddy,et al.  Modulation of life and death by the TNF receptor superfamily , 1998, Oncogene.

[35]  Y. Iwakura,et al.  Involvement of Fas/Fas ligand system‐mediated apoptosis in the development of concanavalin A‐induced hepatitis , 1998, European journal of immunology.

[36]  J. Boyer,et al.  Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J P Luzio,et al.  Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. , 1998, Science.

[38]  M. Peter,et al.  Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. , 1998, Current opinion in immunology.

[39]  J. Tschopp,et al.  Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.

[40]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[41]  D. Lacey,et al.  Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor–induced apoptosis in vivo and in vitro , 1998, Hepatology.

[42]  L. Moldawer,et al.  Disparate Roles for TNF-α and Fas Ligand in Concanavalin A-Induced Hepatitis , 1998, The Journal of Immunology.

[43]  K. Zatloukal,et al.  Lessons from Keratin 18 Knockout Mice: Formation of Novel Keratin Filaments, Secondary Loss of Keratin 7 and Accumulation of Liver-specific Keratin 8-Positive Aggregates , 1998, The Journal of cell biology.

[44]  E. Fuchs,et al.  A structural scaffolding of intermediate filaments in health and disease. , 1998, Science.

[45]  Jennifer,et al.  Simple epithelium keratins are required for maintenance of hepatocyte integrity. , 1997, The American journal of pathology.

[46]  George Kollias,et al.  In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis , 1997, European journal of immunology.

[47]  G. Salvesen,et al.  Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell Apoptosis , 1997, The Journal of cell biology.

[48]  Y. Iwakura,et al.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.

[49]  M. Omary,et al.  Intermediate filament proteins of the liver: Emerging disease association and functions , 1997, Hepatology.

[50]  A. Klippel,et al.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.

[51]  C. Sarraf,et al.  Reversal of phenobarbital‐induced hyperplasia and hypertrophy in the livers of lpr mice , 1997, International journal of experimental pathology.

[52]  J. Fox,et al.  Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis , 1996, Infection and immunity.

[53]  M. Benito,et al.  Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. , 1996, The Journal of biological chemistry.

[54]  H. Isom,et al.  Apoptosis induced by tumor necrosis factor-alpha in rat hepatocyte cell lines expressing hepatitis B virus. , 1996, The American journal of pathology.

[55]  A. Chinnaiyan,et al.  FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[56]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[57]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[58]  R. Mulligan,et al.  Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[60]  R. Iozzo,et al.  Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. , 1994, Genes & development.

[61]  S. Nagata,et al.  Fas-mediated apoptosis in primary cultured mouse hepatocytes. , 1994, Experimental cell research.

[62]  M. Leist,et al.  Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. , 1994, Journal of immunology.

[63]  W. Dalton,et al.  Expression of cytokeratin confers multiple drug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[64]  S. Goff,et al.  A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.

[65]  M. Kirschner,et al.  Autoregulation of tubulin synthesis in hepatocytes and fibroblasts , 1985, The Journal of cell biology.

[66]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[67]  B. Viollet,et al.  Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice , 1996, Nature Medicine.

[68]  E. Lane,et al.  Intermediate filaments in disease. , 1995, Current opinion in cell biology.

[69]  P. Seglen Preparation of isolated rat liver cells. , 1976, Methods in cell biology.